Answered step by step
Verified Expert Solution
Link Copied!

Question

1 Approved Answer

Could someone please verify if this balances? If not please explain and show why not. Current assets Current ratio = Current liabilities Total Assets Equity

Could someone please verify if this balances? If not please explain and show why not.

image text in transcribed Current assets Current ratio = Current liabilities Total Assets Equity Multipiler Total Equity Cost of goods sold Inventory Turnover = Average inventory 365 days Days in inventory = Inventory turnover ratio Gross profit Gross profit Margin Revenue Net Earnings Return on Assets Total Assets total liabilities debt ratio = total assets EBIT times interest earned ratio = interest expense Revenue Net Profit Margins Research and development Selling, general and administrative Total operating expenses Operating income Other income/(expense), net Income before provision for income taxes Provision for income taxes Net income Dupont Total Stockholder equity Total Liabilities Total Assets Net Sales Net Income Profit Margin = NI/Sales Return On Asset = NI/A Return On Equity = NI/E 2016 2015 2016 2015 Income Statement All numbers in thousands Revenue Total Revenue Cost of Revenue Gross Profit Operating Expenses Research Development Selling General and Administrative Non Recurring Others Total Operating Expenses Operating Income or Loss Income from Continuing Operations Total Other Income/Expenses Net Earnings Before Interest and Taxes Interest Expense Income Before Tax Income Tax Expense Minority Interest Net Income From Continuing Ops Non-recurring Events Discontinued Operations Extraordinary Items Effect Of Accounting Changes Other Items Net Income Net Income Preferred Stock And Other Adjustments Net Income Applicable To Common Shares Cash Flow All numbers in thousands Period Ending Net Income Operating Activities, Cash Flows Provided By or Used In Depreciation Adjustments To Net Income Changes In Accounts Receivables Changes In Liabilities Changes In Inventories Changes In Other Operating Activities Total Cash Flow From Operating Activities Investing Activities, Cash Flows Provided By or Used In Capital Expenditures Investments Other Cash flows from Investing Activities Total Cash Flows From Investing Activities Financing Activities, Cash Flows Provided By or Used In Dividends Paid Sale Purchase of Stock Net Borrowings Other Cash Flows from Financing Activities Total Cash Flows From Financing Activities Effect Of Exchange Rate Changes Change In Cash and Cash Equivalents Balance Sheet All numbers in thousands Period Ending Current Assets Cash And Cash Equivalents Short Term Investments Net Receivables Inventory Other Current Assets Total Current Assets Long Term Investments Property Plant and Equipment Goodwill Intangible Assets Accumulated Amortization Other Assets Deferred Long Term Asset Charges Total Assets Current Liabilities Accounts Payable Short/Current Long Term Debt Other Current Liabilities Total Current Liabilities Long Term Debt Other Liabilities Deferred Long Term Liability Charges Minority Interest Negative Goodwill Total Liabilities Stockholders' Equity Misc. Stocks Options Warrants Redeemable Preferred Stock Preferred Stock Common Stock Retained Earnings Treasury Stock Capital Surplus Other Stockholder Equity Total Stockholder Equity Net Tangible Assets CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) Income Statement [Abstract] Net sales Cost of sales Gross margin Operating expenses: Research and development Selling, general and administrative Total operating expenses Operating income Other income/(expense), net Income before provision for income taxes Provision for income taxes Net income Earnings per share: Basic (in dollars per share) Diluted (in dollars per share) Shares used in computing earnings per share: Basic (in shares) Diluted (in shares) Cash dividends declared per share (in dollars per sha 2016 2015 321686 290345 1.6630013906 193437 1.698023276 170990 321,686,000 290,345,000 2.5082924623 2.432616983 128,249,000 119,355,000 131376 140089 61.621013133 59.63771818 2132 2349 365 365 5.9233041043 6.120287817 61.6210131332 59.6377181779 84,263,000 93,626,000 0.3907595565 0.40059902 215,639,000 233,715,000 45,687,000 53,394,000 0.1420235882 0.183898466 321,686,000 290,345,000 193437 170990 0.6013224076 0.588920078 321686 290345 61372 72515 #DIV/0! #DIV/0! 0 0 215,639,000 233,715,000 $927.10 10,045 14,194 24,239 60,024 1,348 890.8960612 8,067 14,329 22,396 71,230 1,285 61,372 15,685 $45,687 $232,594 72,515 19,121 $53,394 262,337 128,249,000 79,006,000 321,686,000 215,639,000 45,687,000 119,355,000 80,610,000 290,345,000 233,715,000 53,394,000 0.2118679831 0.1420235882 0.3562366958 0.228457737 0.1838984656 0.4473545306 profit margin Asset Turnover Equity multipiler NI/Sales Sales/Assets Assets/Equity ROE Product 0.2118679831 0.670340021 2.5082924623 0.356236696 0.228457737 0.8049561728 2.432616983 0.447354531 ROA Product 0.1420235882 0.1838984656 ROA 1+D/E ROE Product 0.1420235882 1.616035992 0.2295152303 0.1838984656 1.675380168 0.3080998423 9/24/2016 215,639,000 131,376,000 84,263,000 9/26/2015 233,715,000 140,089,000 93,626,000 10,045,000 14,194,000 60,024,000 8,067,000 14,329,000 71,230,000 1,348,000 61,372,000 61,372,000 1,285,000 72,515,000 72,515,000 15,685,000 45,687,000 19,121,000 53,394,000 - - 45,687,000 45,687,000 53,394,000 53,394,000 9/24/2016 45,687,000 9/26/2015 53,394,000 10,505,000 9,148,000 1,044,000 -1,867,000 217,000 1,090,000 65,824,000 11,257,000 4,968,000 -3,124,000 15,188,000 -238,000 -179,000 81,266,000 -12,734,000 -32,022,000 -1,221,000 -45,977,000 -11,247,000 -44,417,000 -610,000 -56,274,000 -12,150,000 -29,227,000 22,057,000 -1,570,000 -20,483,000 -636,000 -11,561,000 -34,710,000 29,305,000 -1,499,000 -17,716,000 7,276,000 By or Used In By or Used In By or Used In 9/24/2016 9/26/2015 20,484,000 46,671,000 29,299,000 2,132,000 8,283,000 106,869,000 170,430,000 27,010,000 5,414,000 3,206,000 8,757,000 321,686,000 21,120,000 20,481,000 30,343,000 2,349,000 15,085,000 89,378,000 164,065,000 22,471,000 5,116,000 3,893,000 5,422,000 290,345,000 59,321,000 11,605,000 8,080,000 79,006,000 75,427,000 36,074,000 2,930,000 193,437,000 60,671,000 10,999,000 8,940,000 80,610,000 53,329,000 33,427,000 3,624,000 170,990,000 31,251,000 96,364,000 634,000 128,249,000 119,629,000 27,416,000 92,284,000 -345,000 119,355,000 110,346,000 12 Months Ended Sep. 24, 2016 Sep. 26, 2015 $215,639 131,376 $233,715 140,089 84,263 93,626 10,045 14,194 24,239 60,024 1,348 61,372 15,685 $45,687 8,067 14,329 22,396 71,230 1,285 72,515 19,121 $53,394 $8.35 $8.31 $9.28 $9.22 5,470,820 5,500,281 $2.18 5,753,421 5,793,069 $1.98

Step by Step Solution

There are 3 Steps involved in it

Step: 1

blur-text-image

Get Instant Access to Expert-Tailored Solutions

See step-by-step solutions with expert insights and AI powered tools for academic success

Step: 2

blur-text-image_2

Step: 3

blur-text-image_3

Ace Your Homework with AI

Get the answers you need in no time with our AI-driven, step-by-step assistance

Get Started

Recommended Textbook for

Microeconomics

Authors: Glenn Hubbard, Anthony O'Brien

7th Edition

0134737504, 978-0134737508

More Books

Students also viewed these Finance questions

Question

Draw a stereoisomer of trans-1, 3-climethylcyclobutane.

Answered: 1 week ago